The Psilocybin Behavioral Health Access and Services Act seeks to create a regulated framework for the production, use, and administration of psilocybin in New Jersey, particularly for behavioral health treatment. The bill decriminalizes psilocybin-related activities for individuals aged 21 and older, allowing for personal cultivation and providing a pathway for individuals with past convictions to seek resentencing or expungement. It establishes the Psilocybin Behavioral Health Access and Services Advisory Board within the Department of Health (DOH) to oversee the implementation of the act, develop licensing requirements, and ensure compliance with public health standards. The DOH is also tasked with regulating psilocybin services, issuing licenses, and maintaining safety standards, while prohibiting the requirement of specific medical diagnoses for access to psilocybin services.

Additionally, the bill introduces a social opportunity program to assist individuals from distressed areas in obtaining licenses for psilocybin-related businesses, with reduced fees and technical assistance. It mandates that psilocybin products must not be chemically synthesized and allows naturally grown mushrooms to be used, while also requiring that all psilocybin services be conducted under supervision. The legislation emphasizes public health and safety, including guidelines for advertising, client confidentiality, and the secure handling of psilocybin products. Overall, the act aims to promote safe access to psilocybin as a therapeutic option while addressing past legal repercussions for individuals previously penalized under outdated laws.